SDS

Section 11. Toxicological information
Not available.
May cause damage to organs through prolonged or repeated exposure. Once
sensitized, a severe allergic reaction may occur when subsequently exposed to very low
levels.
General
:
No known significant effects or critical hazards.
Carcinogenicity
:
No known significant effects or critical hazards.
Mutagenicity
:
Suspected of damaging the unborn child.
Teratogenicity
:
Developmental effects
:
No known significant effects or critical hazards.
Fertility effects
:
Suspected of damaging fertility.
Skin contact
Ingestion
Inhalation
Adverse symptoms may include the following:
respiratory tract irritation
coughing
nausea or vomiting
headache
drowsiness/fatigue
dizziness/vertigo
unconsciousness
reduced fetal weight
increase in fetal deaths
skeletal malformations
Adverse symptoms may include the following:
stomach pains
reduced fetal weight
increase in fetal deaths
skeletal malformations
Adverse symptoms may include the following:
pain or irritation
redness
blistering may occur
reduced fetal weight
increase in fetal deaths
skeletal malformations
:
:
:
Potential chronic health effects
Delayed and immediate effects and also chronic effects from short and long term exposure
Numerical measures of toxicity
Oral
1175.49 mg/kg
Dermal
2068.66 mg/kg
Inhalation (gases)
82800 ppm
Inhalation (vapors)
18.4 mg/l
Route
ATE value
Acute toxicity estimates
Potential immediate
effects
:
Not available.
Short term exposure
Potential delayed effects
:
Not available.
Potential immediate
effects
:
Not available.
Long term exposure
Potential delayed effects
:
Not available.
Date of issue/Date of revision
:
4/19/2021
Date of previous issue
:
11/4/2020
Version
:
9
10/15
K05409005
KRYLON® DURA-TOP Floor Coating (Part B)
Hardener
SHW-85-NA-GHS-US